← Back to Search

Behavioural Intervention

SparkRx for Depression (sparkrxt Trial)

N/A

Waitlist Available

Led By Julie Germann, PhD.

Research Sponsored by Limbix Health, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up screening

Awards & highlights

sparkrxt Trial Summary

This trial will evaluate using a mobile app to treat adolescent depression in specialty medical care settings at CHST.

Eligible Conditions

Depression
Obesity
Adolescent Behaviors
Emotional Disturbance
Blood Diseases
Major Depressive Episode
Cancer

sparkrxt Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility of intervention: Completion adherence

Feasibility of intervention: Eligibility

Feasibility of intervention: Module adherence

+2 more

Secondary outcome measures

Adverse events

Depressive Symptoms

Engagement

+1 more

Other outcome measures

Caregiver burden

Depressive Symptoms

Caregiver proxy treatment-related change in global functioning

+9 more

sparkrxt Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: SparkRxExperimental Treatment1 Intervention

5-week CBT-based mobile intervention for adolescents with depressive symptoms

Group II: Educational ControlActive Control1 Intervention

5-week mobile control with education about depression

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Children's Health System, Inc.OTHER

3 Previous Clinical Trials

417 Total Patients Enrolled

Children's HealthOTHER

7 Previous Clinical Trials

712 Total Patients Enrolled

Limbix Health, Inc.Lead Sponsor

7 Previous Clinical Trials

721 Total Patients Enrolled

5 Trials studying Depression

641 Patients Enrolled for Depression

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do participants of this research need to be over 25 years old?

"Those hoping to join this study must be aged between 13 and 22 years old, according to the inclusion criteria."

Answered by AI

Who is qualified to participate in this medical experiment?

"This clinical trial is seeking 70 patients between the tender ages of 13 and 22 with a diagnosis of obesity."

Answered by AI

Are participants still being enrolled in this experiment?

"According to clinicaltrials.gov, this research project is not presently seeking participants - it was initially published on 26th January 2023 and edited for the last time on 16th February 2023. However, there are 3971 other studies that currently require patients' involvement."

Answered by AI

What is the specific aim of this research endeavor?

"According to Limbix Health, Inc., the main assessment for this trial's primary outcome is Eligibility Feasibility over a Screening period. Additional metrics being monitored include Usability (measured with System Usability Scale), Change in Depressive Symptoms (Patient Health Questionnaire [PHQ-8]), Clinically Significant Improvement (>= 5 reduction of score), Treatment Response (50% decrease from pre-intervention baseline symptoms) Remission (<5 score), and Adverse Events/Side Effects rates."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Digital Therapeutic for Adolescent Depressive Symptoms in Hematology, Oncology, and Weight Management

2023. "Digital Therapeutic for Adolescent Depressive Symptoms in Hematology, Oncology, and Weight Management". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05351866.